Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. - Wikidata - wikimedia - TriplyDB

Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.

Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.

http://www.wikidata.org/entity/Q36110382

about

Microtubule-binding agents: a dynamic field of cancer therapeutics.First- and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view.Gemcitabine and carboplatin combination chemotherapy for elderly patients with advanced Non-Small Cell Lung Cancer: a feasibility study.[A randomized clinical trial on the clinical efficacy and toxicities of single-agent paclitaxel liposome versus paclitaxel liposome plus oxaliplatin as first-line chemotherapy for advanced non-small cell lung cancer in elderly patients].Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901.Epidermal growth factor receptor tyrosine kinase inhibitors for elderly patients with advanced non-small cell lung cancer.Chemotherapy and other systemic therapies for hepatocellular carcinoma and liver metastases.Treating advanced non-small cell lung cancer in the elderly.Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer Chemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung Cancer Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients.Outcome of active anti-cancer treatment in elderly patients with advanced non-small cell lung cancer: A single center experience.Toxicity of initial chemotherapy in older patients with lung cancers.Tolerance to chemotherapy in elderly patients with cancer.Improving Outcomes in Advanced Lung Cancer: Maintenance therapy in non-small-cell lung carcinoma.Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.Weekly low-dose docetaxel for salvage chemotherapy in pretreated elderly or poor performance status patients with non-small cell lung cancer.DNA microarray reveals different pathways responding to paclitaxel and docetaxel in non-small cell lung cancer cell line.Variations in Oncologist Recommendations for Chemotherapy for Stage IV Lung Cancer: What Is the Role of Performance Status?Non-small cell lung cancer in the elderly: defining treatment options.Age is a prognostic factor affecting survival in lung cancer patients.Therapeutic strategy for treatment of metastatic non-small cell lung cancer.Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.Treatment of cardiovascular diseases in cancer patients.Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.Clinical outcomes in patients with advanced EGFR-mutated non-small cell lung cancer in South Western Sydney Local Health District.Treatment complexity: a description of chemotherapy and supportive care treatment visits in patients with advanced-stage cancer diagnoses.The effects of advanced age and serum α1 -acid glycoprotein on docetaxel unbound exposure and dose-limiting toxicity in cancer patients.Low dose fractionated cisplatin plus gemcitabine for elderly patients with advanced non small cell lung cancer: a retrospective analysis.When less is better: the safety and efficacy of reduced intensity gemcitabine in a difficult patient population with advanced non-small-cell lung cancer.Analysis of multidisciplinary lung cancer practice.Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study.Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System.Treatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: results from a Delphi panel.Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study.Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer.Lung cancer, elderly and immune checkpoint inhibitors.[The status and prospects of treatment protocols for elderly patients with non-small cell lung cancer].

P2860

Q27690249-490D1A18-5237-4A2B-8120-49C6B19B5551 Q33373493-D11A6A2D-4CB2-4DE7-BDD0-06B44CE4691D Q33385869-DEE1F6BA-D3BA-46A1-BC73-95CB2B0E9448 Q33399713-D465F526-BD30-446B-AA05-71ACA58D11FF Q33406653-3A12DA3F-7BB1-4A96-826B-C3C9921855EB Q34001991-5378EF8F-60C8-4D03-946B-DD18293A1896 Q34563336-BC385489-FD29-488F-9D7D-EE8D0B9F3E7B Q35076283-2A2AF760-3A13-4493-866D-140B6DDBDBFD Q35535417-30681C2B-4237-492E-9FA0-51AADC984E64 Q35877754-73BD2C5D-DF2A-4895-89A5-F7560B01307A Q36299985-042CE209-5A13-499F-AF6A-BCA804C7FF75 Q36439388-033B451A-8B1F-4477-B024-FBA849BF8662 Q36697134-29C21694-DC85-40F5-ABEE-88368DCACC98 Q36715266-B06D89BC-C6EC-4702-90C2-AAB7B02AF1F5 Q36741073-F3D2B5BF-4F9F-4CF4-AED1-7BF429FD2035 Q36924607-968673D8-4792-4F5C-9A05-B27E032081FF Q37030260-E7E2A553-C7F8-4514-B891-A55F8EF6AE67 Q37054550-74AC0EF3-4C1F-416F-8864-6091CEF6103A Q37117859-70E11E70-B788-432E-98C5-487B1A1C54B1 Q37240128-A6886D5D-7B41-49B2-8075-D21FCFAB173C Q37269229-294A53ED-4B3D-44AB-A5CB-BE3799D7C050 Q37310694-AF8E5C35-FFBA-4FF7-8C93-75366BE7DDB3 Q37551919-B618E051-0D8C-4E43-A63F-2B06E7A55141 Q37876349-FEFB8D7C-DF7F-493E-AC49-6BFB92510188 Q39095223-435DB9EE-486A-414C-B444-BBC1DE34BF02 Q39457284-8ED99AC8-4896-45E8-BFEA-A6DB88D2B77D Q40886395-53EEB997-96FC-4A06-ABF5-F5A54D83B261 Q42656439-4530E45D-80E4-4584-9832-D6D9BADD02E5 Q42946326-FB1B4E16-6201-484C-BD59-196944E5E9B0 Q44013570-B1A9D5DC-FABB-4DD7-B1F5-5C67F49BAD83 Q44062615-94DEEFD2-5B9E-4505-BE8B-34464651691E Q48706070-82144D3C-734E-4849-9A26-01D4F2E7A8A3 Q49441931-292E9914-F8C3-4130-96FA-4D54009934B0 Q51546419-A6265631-986B-4744-B642-2812D1222FDE Q53277355-399CFAFE-E630-4603-8C09-39A7BD1F03D6 Q54582444-84E70EC0-3CE4-4543-A19A-BFE06784A12F Q55338007-3481676F-0AE6-424F-B9A3-1C8A880A0AB6 Q55451743-32385634-1D62-472B-8235-C4CF8870B7D5

P2860

Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.

http://www.wikidata.org/entity/Q36110382

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Treatment of advanced non-smal ...... an international expert panel.

@ast

Treatment of advanced non-smal ...... an international expert panel.

@en

type

label

Treatment of advanced non-smal ...... an international expert panel.

@ast

Treatment of advanced non-smal ...... an international expert panel.

@en

prefLabel

Treatment of advanced non-smal ...... an international expert panel.

@ast

Treatment of advanced non-smal ...... an international expert panel.

@en

P1433

Q36110382-A6479FAB-DC96-4C84-B38F-DF4E064DA71F

P1476

Q36110382-C41BBE56-C31E-4657-9B92-4D28884337AF

P2093

Q36110382-05FBCBB7-67B5-458C-85AD-77B62EC4F0B7

Q36110382-0F55857D-093A-4AF7-98BC-49CE3D762687

Q36110382-3047B8F0-5188-44CA-AB56-F334B38F9662

Q36110382-4C23009E-4CA0-459D-B030-A72BF75FBF2D

Q36110382-6D773DD5-C3BB-4DB8-BC5B-C635312EC66D

Q36110382-71134D43-62AE-4F40-9491-5DB134A46E58

Q36110382-91EF5DBC-47BF-4D27-87D1-3A7EEEAF69F1

Q36110382-BF4D981F-95D3-42E5-9476-BB072DC381E4

Q36110382-DE700AA0-B96D-462A-9CC4-703F44258FA4

Q36110382-E921534A-50EA-473B-965B-6DACAD6B8EC7

P304

Q36110382-0E7FAAA1-610D-44B1-95E6-12A0604BAE4E

P31

Q36110382-C6DD497D-9E28-4201-AC1F-164DDC5928AC

P356

Q36110382-AAF29996-B564-4932-AFE3-854298DCEFBD

P407

Q36110382-71475F49-B5F3-4E9B-BA66-2D4830F38273

P433

Q36110382-2000B097-A467-4D6D-910A-79D71E036B6B

P478

Q36110382-ADE5547A-60CC-4A17-8A52-6B6A283CC375

P50

Q36110382-2D9C0423-9B33-43E7-907D-E32781EF5A58

Q36110382-AA8620FA-DC1F-42DD-8A5E-874B856E1856

Q36110382-F6435C7B-8165-4E98-BE47-8EB1D6C24DF5

P577

Q36110382-419C1079-919D-4D76-B39A-878347448C0E

P698

Q36110382-120B731D-4B13-4CFD-A44D-B83FC9B56530

P356

JCO.2005.00.224

P1433

Journal of Clinical Oncology

P1476

Treatment of advanced non-smal ...... an international expert panel.

@en

P2093

Andrea Ardizzoni

http://www.w3.org/2001/XMLSchema#string

Christian Manegold

http://www.w3.org/2001/XMLSchema#string

Corey Langer

http://www.w3.org/2001/XMLSchema#string

Filippo De Marinis

http://www.w3.org/2001/XMLSchema#string

Frances Shepherd

http://www.w3.org/2001/XMLSchema#string

Francesco Perrone

http://www.w3.org/2001/XMLSchema#string

Karen Kelly

http://www.w3.org/2001/XMLSchema#string

Lodovico Balducci

http://www.w3.org/2001/XMLSchema#string

Luigi De Petris

http://www.w3.org/2001/XMLSchema#string

Massimo Di Maio

http://www.w3.org/2001/XMLSchema#string

P304

3125-3137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.00.224

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Thierry Le Chevalier

Cesare Gridelli

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15860872

http://www.w3.org/2001/XMLSchema#string